[Contralateral comparison between diflucortolone valeriante and flumethasone pivalate in ointments. Double-blind study].
Double blind study with contralateral comparison, between diflucortolon valerianat, 0.1% and the flumetason pivalat, 0.02% in pomades (ointments). Selection of 52 patients both sexes and variable ages with bilateral dermatological inflamatory lesions and with simetric preference: Psoriasis, "eczema vario" and neurodermatitis. In psoriasis, diflucortolon offered better results: the same occurred in the cases of eczema, and in neurodermatitis. The efficacy was similar. There were no appearances of negative secondary effects because of the used doses and time.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005443:Flumethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000008:administration & dosage / Q000627:therapeutic use*
D014631:Valerates; D005443:Flumethasone
Comparación contralateral entre el valerianato de diflucortolona y el pivalato de flumetasona en pomada. Estudio doble ciego